Moore Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Moore Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-25,000	Closed	-$596K	–	299
2018 Q2	$596K	Sell	25,000 -25,000	-50%	-$615K	0.01%	229
2018 Q1	$1.28M	Sell	50,000 -125,000	-71%	-$2.98M	0.03%	185
2017 Q4	$3.23M	Buy	175,000 +125,000	+250%	+$1.79M	0.06%	169
2017 Q3	$525K	Sell	50,000 -25,000	-33%	-$276K	0.01%	207
2017 Q2	$938K	Sell	75,000 -25,000	-25%	-$247K	0.03%	160
2017 Q1	$1.01M	Sell	100,000 -25,000	-20%	-$372K	0.03%	166
2016 Q4	$1.95M	Buy	+125,000	New	+$2.08M	0.06%	135

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Moore Capital Management's COLL Position: Q3 2018 in Review

Moore Capital Management sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 25,000 shares — an estimated $596K sold.

Moore Capital Management first reported a position in COLL in Q4 2016 and held it in 7 quarters. The position peaked at $3.23M in Q4 2017. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

Moore Capital Management reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
Moore Capital Management sold 25,000 Collegium Pharmaceutical shares in Q3 2018, an estimated $596K.
Moore Capital Management first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 7 quarters.
Moore Capital Management's Collegium Pharmaceutical position peaked at $3.23M in Q4 2017.
124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on Moore Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.